Healthcare Policy
Five Years After Cannabis Legalization, Is It Time to Ease Restrictions on Promotion?
Abstract
In the spring of 2024, the federal government is expected to report on its legislative review of the Cannabis Act (2018). One of the most contentious issues is whether to relax restrictions on cannabis promotion. This commentary describes the tension between the public health aims of legalization and the secondary aim of displacing the illicit market. We maintain that among jurisdictions that have legalized cannabis, Canada stands out as having the stated primary objective of safeguarding public health, and its restrictions on promotion are evidence-based and innovative. These measures must be preserved, even in the face of growing industry pressure to loosen them.
Comments
Be the first to comment on this!
This article is for subscribers only. To view the entire article
Related Articles
Note: Please enter a display name. Your email address will not be publically displayed